Clearline Capital’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $737K | Hold |
635,222
| – | – | 0.03% | 96 |
|
|
2025
Q1 | $588K | Hold |
635,222
| – | – | 0.04% | 102 |
|
|
2024
Q4 | $546K | Sell |
635,222
-1,400
| -0.2% | -$1.2K | 0.07% | 89 |
|
|
2024
Q3 | $1.06M | Hold |
636,622
| – | – | 0.04% | 112 |
|
|
2024
Q2 | $1.02M | Buy |
636,622
+101,282
| +19% | +$163K | 0.03% | 115 |
|
|
2024
Q1 | $1.23M | Buy |
535,340
+69,129
| +15% | +$158K | 0.06% | 97 |
|
|
2023
Q4 | $1.05M | Buy |
466,211
+10,823
| +2% | +$24.4K | 0.06% | 82 |
|
|
2023
Q3 | $1.38M | Buy |
455,388
+16
| +0% | +$48 | 0.12% | 96 |
|
|
2023
Q2 | $1.88M | Buy |
455,372
+35,947
| +9% | +$148K | 0.11% | 76 |
|
|
2023
Q1 | $1.57M | Buy |
419,425
+185,385
| +79% | +$695K | 0.24% | 66 |
|
|
2022
Q4 | $1.31M | Buy |
+234,040
| New | +$1.31M | 0.23% | 79 |
|
|
2020
Q4 | – | Sell |
-14,579
| Closed | -$1.15M | – | 96 |
|
|
2020
Q3 | $1.15M | Buy |
+14,579
| New | +$1.15M | 0.3% | 60 |
|
|
2020
Q1 | – | Sell |
-616
| Closed | -$75K | – | 86 |
|
|
2019
Q4 | $75K | Buy |
+616
| New | +$75K | 0.03% | 54 |
|
|
2017
Q1 | – | Sell |
-935
| Closed | -$270K | – | 67 |
|
|
2016
Q4 | $270K | Buy |
+935
| New | +$270K | 0.12% | 45 |
|